Anti-TNF therapy efficacious for preventing endoscopic recurrence in Crohn’s

After surgery for Crohn’s disease, anti-tumor necrosis factor therapy was efficacious for preventing endoscopic recurrence without an increase in the incidence of adverse events, according to study results.“However, clinical recurrence was not significantly reduced,” Motoi Uchino, MD, PhD, from the department of inflammatory bowel disease at Hyogo College of Medicine, and colleagues wrote. “The efficacy of postoperative antiTNF therapy may differ in terms of the outcomes, which include longterm prevention, the avoidance of further surgery and costeffectiveness.”Read More

Share on facebook
Share on twitter
Share on linkedin